AREPANRIX Trademark

Trademark Overview


On Friday, February 17, 2017, a trademark application was filed for AREPANRIX with the United States Patent and Trademark Office. The USPTO has given the AREPANRIX trademark a serial number of 87340185. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 2, 2024. This trademark is owned by GlaxoSmithKline Biologicals S.A.. The AREPANRIX trademark is filed in the Pharmaceutical Products category with the following description:

Human vaccine preparations
arepanrix

General Information


Serial Number87340185
Word MarkAREPANRIX
Filing DateFriday, February 17, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 2, 2024
Registration Number5246527
Registration DateTuesday, July 18, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2017

Trademark Statements


Goods and ServicesHuman vaccine preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Friday, February 2, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, August 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 2, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, August 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 18, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 18, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, May 2, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 18, 2017ASSIGNED TO EXAMINER
Friday, February 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 21, 2017NEW APPLICATION ENTERED

Related Keywords


arepanrix preparations vaccine human